Aptevo Therapeutics Inc. Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
Aptevo Therapeutics Inc. (APVO) reported Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal of $9.65 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Income Statement › Other Income
us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal · last filed 2025-02-14
- Aptevo Therapeutics Inc. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2023-12-31 was $0.00.
- Aptevo Therapeutics Inc. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2023-09-30 was $0.00.
- Aptevo Therapeutics Inc. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2023-06-30 was $0.00.
- Aptevo Therapeutics Inc. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2023-03-31 was $9.65M.
- Aptevo Therapeutics Inc. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2023 was $9.65M.
- Aptevo Therapeutics Inc. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2020 was $14.34M, a 237.36% increase from fiscal 2019.
- Aptevo Therapeutics Inc. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2019 was $4.25M.
- Aptevo Therapeutics Inc. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2017 was $52.70M.
| Period end | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 3 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 6 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 9 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $0.00 derived: sum of 2 quarters · filed 2025-02-14 | $0.00 derived: sum of 3 quarters · filed 2025-02-14 | $9.65M 10-K · filed 2025-02-14 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $9.65M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $9.65M 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $9.65M 10-Q · filed 2024-05-08 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $0.00 derived: sum of 2 quarters · filed 2022-03-24 | $0.00 derived: sum of 3 quarters · filed 2022-03-24 | $14.34M 10-K · filed 2022-03-24 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $14.34M 10-Q · filed 2021-11-12 | $14.34M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $14.34M 10-Q · filed 2021-08-12 | $14.34M derived: sum of 3 quarters · filed 2021-08-12 | |
| 2020-03-31 | $14.34M 10-Q · filed 2021-05-11 | $14.34M derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $4.25M 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $4.25M 10-Q · filed 2019-11-07 | |||
| 2017-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $52.70M 10-K · filed 2019-03-18 | ||
| 2017-09-30 | $52.54M 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |